Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: A randomized controlled trial

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Leelarathna, Lalantha ^a   English, Shane W ^b   Thabit, Hood ^a   Caldwell, Karen ^a   Allen, Janet M ^a   Kumareswaran, Kavita ^a   Wilinska, Malgorzata E ^a   Nodale, Marianna ^a   Mangat, Jasdip ^a   Evans, Mark L ^a   Burnstein, Rowan ^b   Hovorka, Roman ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DOBUTAMINE; GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; AGED; APACHE; ARTICLE; AUTOMATION; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ARTICLE; CLOSED LOOP GLUCOSE CONTROL; COMPUTER MODEL; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIETARY INTAKE; ENTERIC FEEDING; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INDUCED HYPOTHERMIA; INFUSION PUMP; INJURY; INSULIN INFUSION; INSULIN TREATMENT; INTENSIVE CARE UNIT; MALE; OPEN STUDY; PARALLEL DESIGN; PARENTERAL NUTRITION; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; CROSSOVER PROCEDURE; DEVICES; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PHYSIOLOGIC MONITORING; PROCEDURES; SUBCUTANEOUS TISSUE; VASCULARIZATION;

BLOOD GLUCOSE; CRITICAL ILLNESS; CROSS-OVER STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROSPECTIVE STUDIES; SUBCUTANEOUS TISSUE;

EID: 84880349426     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12838     Document Type: Article

References (52)

1. Kavanagh BP, McCowen KC. Clinical practice: glycemic control in the ICU. N Engl J Med 2010, 363(26):2540-2546. 10.1056/NEJMcp1001115, 21175316.
2. Krinsley JS. Understanding glycemic control in the critically ill: three domains are better than one. Intensive Care Med 2011, 37(3):382-384. 10.1007/s00134-010-2110-3, 21210079.
3. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78(12):1471-1478. 10.4065/78.12.1471, 14661676.
4. Bochicchio GV, Joshi M, Bochicchio KM, Pyle A, Johnson SB, Meyer W, Lumpkins K, Scalea TM. Early hyperglycemic control is important in critically injured trauma patients. J Trauma 2007, 63(6):1353-1358. discussion, 1358-1359, 10.1097/TA.0b013e31815b83c4, 18212660.
5. Bagshaw SM, Egi M, George C, Bellomo R, . Australia New Zealand Intensive Care Society Database Management C Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009, 37(2):463-470. 10.1097/CCM.0b013e318194b097, 19114915, Australia New Zealand Intensive Care Society Database Management C.
6. Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG. NICE-SUGAR Study Investigators Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012, 367(12):1108-1118. NICE-SUGAR Study Investigators.
7. Hermanides J, Bosman RJ, Vriesendorp TM, Dotsch R, Rosendaal FR, Zandstra DF, Hoekstra JB, DeVries JH. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med 2010, 38(6):1430-1434. 10.1097/CCM.0b013e3181de562c, 20386307.
8. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105(2):244-252. 10.1097/00000542-200608000-00006, 16871057.
9. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008, 36(11):3008-3013. 10.1097/CCM.0b013e31818b38d2, 18824908.
10. Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 2012, 40(12):3180-3188. 10.1097/CCM.0b013e3182656ae5, 22971590.
11. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009, 373(9677):1798-1807. 10.1016/S0140-6736(09)60553-5, 3144755, 19465235.
12. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345(19):1359-1367. 10.1056/NEJMoa011300, 11794168.
13. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354(5):449-461. 10.1056/NEJMoa052521, 16452557.
14. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360(13):1283-1297. NICE-SUGAR Study Investigators.
15. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chiolero R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol Study. Intensive Care Med 2009, 35(10):1738-1748. 10.1007/s00134-009-1585-2, 19636533.
16. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180(8):821-827. 10.1503/cmaj.090206, 2665940, 19318387.
17. Van den Berghe G. Intensive insulin therapy in the ICU: reconciling the evidence. Nature Rev Endocrinol 2012, 8(6):374-378.
18. Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. J Clin Endocrinol Metab 2009, 94(9):3163-3170. 10.1210/jc.2009-0663, 19531590.
19. Van Herpe T, De Moor B, Van den Berghe G. Towards closed-loop glycaemic control. Best Pract Res Clin Anaesthesiol 2009, 23(1):69-80. 10.1016/j.bpa.2008.07.003, 19449617.
20. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006, 15(4):370-377.
21. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359(14):1464-1476. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.
22. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011, 343:d3805. 10.1136/bmj.d3805, 3131116, 21737469.
23. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, Meertens JH, Zijlstra JG. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care 2006, 10(5):R135. 10.1186/cc5048, 1751062, 16981981.
24. Siegelaar SE, Barwari T, Hermanides J, Stooker W, van der Voort PH, DeVries JH. Accuracy and reliability of continuous glucose monitoring in the intensive care unit: a head-to-head comparison of two subcutaneous glucose sensors in cardiac surgery patients. Diabetes Care 2011, 34(3):e31. 10.2337/dc10-1882, 3041230, 21357356.
25. Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med 2009, 35(8):1383-1389. 10.1007/s00134-009-1471-y, 19350213.
26. Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nature Rev Endocrinol 2011, 7(7):385-395.
27. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. a review. Control Clin Trials 2002, 23(6):662-674. 10.1016/S0197-2456(02)00242-8, 12505244.
28. Minim: allocation by minimisation in clinical trials Minim: allocation by minimisation in clinical trials., http://www-users.york.ac.uk/~mb55/guide/minim.htm
29. Geoffrey M, Brazg R, Richard W. FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart algorithm, a 1-hour warm-up time. J Diabetes Sci Technol 2011, 5(1):99-106. 3045239, 21303631.
30. Bequette B. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther 2005, 7(1):28-47. 10.1089/dia.2005.7.28, 15738702.
31. Wilinska ME, Blaha J, Chassin LJ, Cordingley JJ, Dormand NC, Ellmerer M, Haluzik M, Plank J, Vlasselaers D, Wouters PJ, Hovorka R. Evaluating glycemic control algorithms by computer simulations. Diabetes Technol Ther 2011, 13(7):713-722. 10.1089/dia.2011.0016, 21488803.
32. Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC, Tudor RS, Umpleby AM, Jones RH. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol Endocrinol Metab 2002, 282(5):E992-1007.
33. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P, . Clinical Guidelines Committee of the American College of P Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011, 154(4):260-267. 10.7326/0003-4819-154-4-201102150-00007, 21320941, Clinical Guidelines Committee of the American College of P.
34. American Diabetes A. Standards of medical care in diabetes: 2012. Diabetes Care 2012, 35(Suppl 1):S11-63. 3632172, 22187469.
35. Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, Freire AX, Geehan D, Kohl B, Nasraway SA, Rigby M, Sands K, Schallom L, Taylor B, Umpierrez G, Mazuski J, Schunemann H. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012, 40(12):3251-3276. 10.1097/CCM.0b013e3182653269, 23164767.
36. Siegelaar SE, Hermanides J, Oudemans-van Straaten HM, van der Voort PH, Bosman RJ, Zandstra DF, DeVries JH. Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Critical Care 2010, 14(6):R224. 10.1186/cc9369, 3219982, 21143980.
37. Balkin M, Mascioli C, Smith V, Alnachawati H, Mehrishi S, Saydain G, Slone H, Alessandrini J, Brown L. Achieving durable glucose control in the intensive care unit without hypoglycaemia: a new practical IV insulin protocol. Diabetes Metab Res Rev 2007, 23(1):49-55. 10.1002/dmrr.673, 16874843.
38. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004, 27(2):461-467. 10.2337/diacare.27.2.461, 14747229.
39. Kanji S, Singh A, Tierney M, Meggison H, McIntyre L, Hebert PC. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 2004, 30(5):804-810. 10.1007/s00134-004-2252-2, 15127193.
40. Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T, Lee D, Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Critical Care 2008, 12(2):R49. 10.1186/cc6868, 2447603, 18412978.
41. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 2005, 28(10):2418-2423. 10.2337/diacare.28.10.2418, 16186273.
42. Vogelzang M, Zijlstra F, Nijsten MW. Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Informat Decision Making 2005, 5:38.
43. Plank J, Blaha J, Cordingley J, Wilinska M, Chassin L, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R. Pieber T Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006, 29(2):271-276. 10.2337/diacare.29.02.06.dc05-1689, 16443872.
44. Pachler C, Plank J, Weinhandl H, Chassin LJ, Wilinska ME, Kulnik R, Kaufmann P, Smolle KH, Pilger E, Pieber TR, Ellmerer M, Hovorka R. Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients. Intensive Care Med 2008, 34(7):1224-1230. 10.1007/s00134-008-1033-8, 18297268.
45. Blaha J, Kopecky P, Matias M, Hovorka R, Kunstyr J, Kotulak T, Lips M, Rubes D, Stritesky M, Lindner J, Semrad M, Haluzik M. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care 2009, 32(5):757-761. 10.2337/dc08-1851, 2671097, 19196894.
46. Cordingley J, Vlasselaers D, Dormand N, Wouters P, Squire S, Chassin L, Wilinska M, Morgan C, Hovorka R, Van den Berghe G. Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care. Intensive Care Med 2009, 35(1):123-128. 10.1007/s00134-008-1236-z, 18661120.
47. Hovorka R, Kremen J, Blaha J, Matias M, Anderlova K, Bosanska L, Roubicek T, Wilinska ME, Chassin LJ, Svacina S, Haluzik M. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab 2007, 92(8):2960-2964. 10.1210/jc.2007-0434, 17550955.
48. Van Herpe T, Mesotten D, Wouters PJ, Herbots J, Voets E, Buyens J, De Moor B, Van den Berghe G. LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial. Diabetes Care 2013, 36(2):188-194. 10.2337/dc12-0584, 22961576.
49. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed 2003, 7(1):43-53. 10.1109/TITB.2003.808509, 12670018.
50. Yatabe T, Yamazaki R, Kitagawa H, Okabayashi T, Yamashita K, Hanazaki K, Yokoyama M. The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients. Crit Care Med 2011, 39(3):575-578. 10.1097/CCM.0b013e318206b9ad, 21178768.
51. Okabayashi T, Kozuki A, Sumiyoshi T, Shima Y. Technical challenges and clinical outcomes of using a closed-loop glycemic control system in the hospital. J Diabetes Sci Technol 2013, 7(1):238-246.
52. Garg SK, Voelmle M, Gottlieb PA. Time lag characterization of two continuous glucose monitoring systems. Diabetes Res Clin Pract 2010, 87(3):348-353. 10.1016/j.diabres.2009.11.014, 20022127.